Dimethyl Fumarate and Monoethyl Fumarate Exhibit Differential Effects on KEAP1, NRF2 Activation, and Glutathione Depletion In Vitro

Delayed-release dimethyl fumarate (also known as gastro-resistant dimethyl fumarate), an oral therapeutic containing dimethyl fumarate (DMF) as the active ingredient, is currently approved for the treatment of relapsing multiple sclerosis. DMF is also a component in a distinct mixture product with 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Brennan, Melanie S., Matos, Maria F., Li, Bing, Hronowski, Xiaoping, Gao, Benbo, Juhasz, Peter, Rhodes, Kenneth J., Scannevin, Robert H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368598/
https://www.ncbi.nlm.nih.gov/pubmed/25793262
http://dx.doi.org/10.1371/journal.pone.0120254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368598/
https://www.ncbi.nlm.nih.gov/pubmed/25793262
http://dx.doi.org/10.1371/journal.pone.0120254

Ejemplares similares